Biogen and City Therapeutics are to partner for the development of new RNA interference (RNAi) therapies. Leveraging ...

The deal tees up a pain treatment market rivalry with Vertex Pharmaceuticals as the industry starts to move away from opioids ...

GSK has made a new drug submission (NDS) to Health Canada for the monoclonal antibody, depemokimab, targeting two specific ...

The 12th Outsourcing in Clinical Trials UK & Ireland conference will focus on the region’s future as a clinical trials hub.

Cell and gene therapy (C&GT) is set to revolutionise treatment of complex diseases, offering new possibilities for patients.

With the 78th World Health Assembly ending today, all eyes have been on this year’s World Health Organization (WHO) member’s ...

The China NMPA's CDE has granted breakthrough therapy designation approval to Abbisko Therapeutics’ irpagratinib for HCC.

Lupin has signed a licence and supply agreement with SteinCares to commercialise its biosimilar ranibizumab in Latin America.

The US FDA has accepted for review Otsuka Pharmaceutical’s biologics licence application (BLA) for the monoclonal antibody, ...

Upperton Pharma Solutions is a winner in the Business Expansion category in the 2025 Pharmaceutical Excellence Awards.

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of ...

The EMA has validated the MAA submitted by Soleno Therapeutics for diazoxide choline prolonged-release tablets for ...